First MRI-Based Method to Measure the Progression of Parkinson's Disease

by Dr. Trupti Shirole on May 28, 2015 at 8:35 AM
First MRI-Based Method to Measure the Progression of Parkinson's Disease

It could soon be possible to measure the progression of Parkinson's disease with the help of a simple test, revealed US researchers. By comparing brain images of Parkinson's patients to those of a control group over a year's period, the researchers found that an area of the brain called the substantia nigra changes as the disease advances.

The substantia nigra of a Parkinson's patient has more 'free water' i.e. fluid unconstrained by brain tissue, likely because of disease-related degeneration. Researchers used diffusion imaging, a type of MRI, to show that free-water levels increase as the disease progresses. This free-water level was also a good predictor of how bradykinesia, the slowness of movement common to Parkinson's, advanced over the course of the subsequent year.


One of the study's authors David Vaillancourt, professor at University of Florida, said, "The findings provide the first magnetic resonance imaging (MRI)-based method to measure the disease's progression, which can inform treatment decisions and aid in identifying new therapies. The Parkinson's drugs available today help reduce symptoms. They do not slow the progression of the disease, which is the major unmet medical need. We have provided a tool to test promising new therapies that could address progression."

The study has been published in the Brain.

Source: Medindia
Font : A-A+



Latest Research News

South Korea's 2050 Forecast: Negative Growth Amid Low Fertility
South Korea's total fertility rate, averaging the number of children a woman aged 15-49 has in her lifetime, dropped to 0.81.
New Immunotherapy for Psoriasis & Vitiligo
Scientists identified mechanisms governing immune cells, selectively removing troublemakers to reshape skin immunity. Benefits those with psoriasis, vitiligo.
2050 Forecast: 1.06 Billion Individuals to Face 'Other' Musculoskeletal Disorders
By 2050, an anticipated increase from 494 million cases in 2020 to 1.06 billion people with musculoskeletal disabilities is expected.
Gene Therapies Can Disrupt Gaucher Disease Drug Market
Experts consulted by GlobalData anticipate a significant overhaul in the Gaucher disease scenario because of forthcoming gene therapies in development.
NASH Cases Expected to Hit 26.55 Million in 7MM by 2032
Within the seven major markets, 12% to 20% of diagnosed prevalent NASH cases present severe liver damage (stage 4 liver fibrosis), denoting cirrhosis.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

First MRI-Based Method to Measure the Progression of Parkinson's Disease Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests